4.8 Editorial Material

Nuclear receptors take center stage in Th17 cell-mediated autoimmunity

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 121, Issue 2, Pages 519-521

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI45939

Keywords

-

Funding

  1. NIAID NIH HHS [R01 AI089954-01, R21 AI091962, R01 AI089954-02, R21 AI091962-01, R21 AI091962-02, AI089954, R01 AI089954, R01 AI089954-03] Funding Source: Medline
  2. NIDDK NIH HHS [R01 DK105562] Funding Source: Medline
  3. NIGMS NIH HHS [T32 GM008061] Funding Source: Medline

Ask authors/readers for more resources

Liver X receptors (LXRs) are nuclear receptors involved in cholesterol homeostasis. Notably, they are also expressed by T cells and are involved in regulating T cell proliferation and differentiation. In this issue of the JCI, Cui et al. have elucidated the molecular mechanism underlying the effects of LXR activation on a subset of T cells known as Th17 cells in mice and humans. Specifically, they showed that LXR-induced Srebp-1 inhibits 111 7 transcription by binding to the 1117 promoter through interaction with the aryl hydrocarbon receptor (Ahr), a transcription factor known to enhance Th17 cell responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available